https://hipss.eu/task/set-the-scene/2026-03-11T11:34:04+00:00https://hipss.eu/task/set-the-scene/administrative-financial-legal/2026-02-05T09:13:50+00:00https://hipss.eu/task/set-the-scene/administrative-financial-legal/i-a-1-general-overview-process-familiarization/2026-03-02T09:15:35+00:00https://hipss.eu/task/define-the-path/clinical-technology/2026-02-05T09:50:07+00:00https://hipss.eu/task/define-the-path/2026-03-11T11:33:16+00:00https://hipss.eu/task/set-the-scene/administrative-financial-legal/i-a-1-template/2026-02-05T09:26:40+00:00https://hipss.eu/task/define-the-path/administrative-financial-legal/2026-02-05T09:09:46+00:00https://hipss.eu/task/define-the-path/market-interaction-business-case-regulatory-hta-payor-interaction/2026-02-05T09:54:32+00:00https://hipss.eu/task/define-the-path/market-interaction-business-case-regulatory-hta-payor-interaction/ii-c-3-analysis-of-the-regulatory-landscape/2026-03-02T09:40:15+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/2026-03-11T11:40:05+00:00https://hipss.eu/task/set-the-scene/administrative-financial-legal/i-a-3-preliminary-funding-sources-and-opportunities-mapped/2026-03-02T09:16:30+00:00https://hipss.eu/task/set-the-scene/administrative-financial-legal/i-a-4-strategic-internal-alignment-and-leadership-commitment-secured/2026-02-06T13:47:33+00:00https://hipss.eu/task/set-the-scene/technical-clinical-technology/2026-02-06T14:24:32+00:00https://hipss.eu/task/set-the-scene/technical-clinical-technology/i-b-1-unmet-need-identified/2026-02-06T14:30:18+00:00https://hipss.eu/task/set-the-scene/market-interaction-regulatory-business-case/2026-02-06T14:31:54+00:00https://hipss.eu/task/set-the-scene/market-interaction-regulatory-business-case/i-c-1-analysis-of-relevant-european-and-international-initiatives/2026-03-05T10:28:41+00:00https://hipss.eu/task/set-the-scene/market-interaction-regulatory-business-case/i-c-2-strategic-policy-and-system-alignment-analysis/2026-02-06T15:34:49+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/administrative-financial-legal/2026-02-06T16:47:37+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/technical-clinical-technology/2026-02-06T15:42:10+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/market-interaction-regulatory-business-case/2026-02-06T15:43:04+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/innovation-providers/2026-02-06T15:45:29+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/administrative-financial-legal/v-a-1-project-evaluation-lessons-learned/2026-02-06T16:11:08+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/administrative-financial-legal/v-a-2-internal-sustainability-assessment-and-follow-up-strategy/2026-02-06T16:25:45+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/technical-clinical-technology/v-b-1-internal-technical-evaluation-pros-cons-go-no-go-reported/2026-02-06T16:37:47+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/market-interaction-regulatory-business-case/v-c-1-market-and-technology-trends-review/2026-02-06T16:46:05+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/market-interaction-regulatory-business-case/v-c-2-payor-engagement-and-system-level-adoption/2026-02-06T16:55:15+00:00https://hipss.eu/task/evaluation-sustainability-and-scale-up-of-the-outcomes/innovation-providers/v-d-1-process-evaluation-and-next-steps-definition/2026-02-06T17:05:02+00:00https://hipss.eu/task/define-the-path/administrative-financial-legal/ii-a-1-selection-of-the-innovation-procurement-scheme-opportunities-and-risk/2026-02-25T16:26:23+00:00https://hipss.eu/task/define-the-path/market-interaction-business-case-regulatory-hta-payor-interaction/ii-c-1-preliminary-state-of-the-art-sota-analysis/2026-02-25T17:00:45+00:00https://hipss.eu/task/define-the-path/market-interaction-business-case-regulatory-hta-payor-interaction/ii-c-2-preliminary-evidence-collection-to-support-the-value-case/2026-02-25T17:05:27+00:00https://hipss.eu/task/define-the-path/administrative-financial-legal/ii-a-2-additional-funding-sources-to-support-the-selected-instrument/2026-03-02T09:35:37+00:00https://hipss.eu/task/define-the-path/administrative-financial-legal/ii-a-3-instrument-selected-and-legal-framework-understood/2026-02-26T10:27:09+00:00https://hipss.eu/task/define-the-path/administrative-financial-legal/ii-a-4-proposal-and-consortium-building-administrative-part/2026-02-26T10:53:32+00:00https://hipss.eu/task/define-the-path/clinical-technology/ii-b-1-proposal-writing-concept-note/2026-02-26T11:21:47+00:00https://hipss.eu/task/define-the-path/clinical-technology/ii-b-2-proposal-writing-consortium-building/2026-02-26T11:54:00+00:00https://hipss.eu/task/define-the-path/clinical-technology/ii-b-3-proposal-writing-common-unmet-needs-and-innovation-challenge-definition/2026-02-26T11:28:17+00:00https://hipss.eu/task/define-the-path/clinical-technology/ii-b-4-proposal-writing-innovation-procurement-methodology/2026-02-26T11:32:42+00:00https://hipss.eu/task/define-the-path/clinical-technology/ii-b-5-proposal-writing-impacts/2026-02-26T12:08:03+00:00https://hipss.eu/task/define-the-path/clinical-technology/ii-b-6-proposal-writing-work-plan/2026-02-26T12:07:33+00:00https://hipss.eu/task/prepare/2026-03-11T11:35:19+00:00https://hipss.eu/task/prepare/market-interaction-regulatory-business-case/2026-02-26T12:13:52+00:00https://hipss.eu/task/prepare/administrative-financial-legal/2026-02-26T12:14:31+00:00https://hipss.eu/task/prepare/technical-clinical-technology/2026-02-26T12:15:16+00:00https://hipss.eu/task/prepare/innovation-providers/2026-02-26T12:47:10+00:00https://hipss.eu/task/prepare/administrative-financial-legal/iii-a-1-administrative-tender-preparation-administrative-team-defined/2026-03-11T11:41:34+00:00https://hipss.eu/task/implement/2026-03-12T15:46:00+00:00https://hipss.eu/task/implement/administrative-financial-legal/2026-02-26T12:42:23+00:00https://hipss.eu/task/implement/technical-clinical-technology/2026-02-26T12:42:35+00:00https://hipss.eu/task/implement/innovation-providers/2026-02-26T12:44:38+00:00https://hipss.eu/task/prepare/administrative-financial-legal/iii-a-2-administrative-tender-preparation-legal-framework-for-tender-and-assessment-defined/2026-02-26T14:47:26+00:00https://hipss.eu/task/prepare/technical-clinical-technology/iii-b-1-technical-tender-preparation-set-up-technical-working-groups/2026-02-26T15:51:28+00:00https://hipss.eu/task/prepare/technical-clinical-technology/iii-b-2-technical-tender-preparation-creation-of-use-cases/2026-04-21T09:09:29+00:00https://hipss.eu/task/prepare/technical-clinical-technology/iii-b-4-technical-tender-preparation-definition-of-functional-and-non-functional-requirements/2026-02-26T15:06:16+00:00https://hipss.eu/task/prepare/technical-clinical-technology/iii-b-4-evaluation-framework-and-impact-assessment/2026-02-26T15:40:32+00:00https://hipss.eu/task/prepare/technical-clinical-technology/iii-b-5-technical-tender-preparation-definition-of-verification-and-validation-procedures/2026-02-26T15:50:06+00:00https://hipss.eu/task/prepare/market-interaction-regulatory-business-case/iii-c-1-in-depth-market-analysis/2026-02-26T16:00:20+00:00https://hipss.eu/task/prepare/market-interaction-regulatory-business-case/iii-c-2-open-market-consultation-omc/2026-02-26T16:53:07+00:00https://hipss.eu/task/prepare/market-interaction-regulatory-business-case/iii-c-3-tender-published-and-disseminated/2026-02-26T16:56:43+00:00https://hipss.eu/task/prepare/innovation-providers/iii-d-1-innovator-pcp-ppi-instruments-process-familiarization/2026-02-27T08:58:29+00:00https://hipss.eu/task/prepare/innovation-providers/iii-d-2-innovator-tender-opportunities-screening-and-assessment/2026-02-26T17:19:38+00:00https://hipss.eu/task/prepare/innovation-providers/iii-d-3-innovator-participation-in-the-omc/2026-02-27T08:47:17+00:00https://hipss.eu/task/prepare/innovation-providers/iii-d-4-build-a-consortium-to-apply-to-a-pcp-ppi-tender/2026-02-27T08:53:38+00:00https://hipss.eu/task/prepare/innovation-providers/iii-d-5-innovator-application-to-a-pcp-ppi-tender/2026-02-27T08:57:29+00:00https://hipss.eu/task/implement/administrative-financial-legal/iv-a-1-proposals-evaluated-and-winner-selected/2026-03-02T07:44:49+00:00https://hipss.eu/task/implement/administrative-financial-legal/iv-a-2-contract-written-and-signed/2026-03-02T08:03:54+00:00https://hipss.eu/task/implement/administrative-financial-legal/iv-a-3-monitoring-team-created/2026-03-02T08:09:16+00:00https://hipss.eu/task/implement/administrative-financial-legal/iv-a-4-supplier-performance-monitoring-and-payment/2026-03-02T08:13:00+00:00https://hipss.eu/task/implement/administrative-financial-legal/iv-a-5-final-project-evaluation-and-closure/2026-03-02T08:15:26+00:00https://hipss.eu/task/implement/technical-clinical-technology/iv-b-2-pcp-phase-ii-monitoring-prototype-development-and-conduct-clinical-validation/2026-03-02T08:57:40+00:00https://hipss.eu/task/implement/technical-clinical-technology/iv-b-2-pcp-phase-ii-monitoring-prototype-development-and-conduct-clinical-validation-2/2026-03-02T08:48:09+00:00https://hipss.eu/task/implement/technical-clinical-technology/iv-b-3-pcp-phase-iii-monitoring-final-prototype-development-including-procurer-adaptations-and-integrations-and-further-pre-clinical-validation-and-preliminary-economic-impact-evaluation-if-appl/2026-03-02T08:52:19+00:00https://hipss.eu/task/implement/technical-clinical-technology/iv-b-4-ppi-monitoring-co-deployment-and-new-process-procedure-validation/2026-03-10T12:24:40+00:00https://hipss.eu/task/implement/innovation-providers/iv-b-1-pcp-phase-i-monitoring-feasibility-study-roadmap-business-model-implementation-plan-further-technical-details-etc-defined/2026-03-09T15:04:57+00:00https://hipss.eu/task/implement/innovation-providers/iv-d-2-pcp-phase-ii-innovators-prototype-development-and-prepare-the-pilots/2026-03-09T15:10:13+00:00https://hipss.eu/task/implement/innovation-providers/iv-d-3-pcp-phase-iii-innovators-final-prototype-development-including-procurer-adaptations-and-integrations-and-further-pre-clinical-validation-and-preliminary-economic-impact-evaluation-if-appl/2026-03-09T15:14:05+00:00https://hipss.eu/task/implement/innovation-providers/iv-d-4-ppi-innovators-co-deployment-and-new-process-procedure-validation/2026-03-09T15:16:38+00:00